Kesimpta (ofatumumab) was more effective than Aubagio (teriflunomide) at suppressing disease activity in people with highly active, relapsing forms of multiple sclerosis (MS), according to new analyses from the Phase 3 ASCLEPIOS trials. After two years, those on Kesimpta were nearly 20 times more likely to achieve…
CMSC Annual Meeting
An app-based, one-to-one peer support program from Shift.ms that connects people newly diagnosed with multiple sclerosis (MS) with someone more experienced may help them feel more confident in managing their condition, with self-reported psychological benefits for both people in the pairing. That’s according to five-year data from the…
Three years of treatment with Sanofi’s investigational antibody therapy frexalimab was associated with persistently low disease activity and no new safety concerns in people with relapsing forms of multiple sclerosis (MS). That’s according to new data from an ongoing open-label extension phase of a global Phase…
Subjective, patient-reported data on lived experiences should always be considered in the care of chronic conditions like multiple sclerosis (MS), according to a recent presentation. In a survey, many people with MS reported feeling that their lived experiences aren’t given enough consideration during visits with their care providers, and…
The understanding and management of neuropsychiatric symptoms such as depression and cognitive difficulties in multiple sclerosis (MS) have advanced substantially, but there’s more progress to be made, said Anthony Feinstein, PhD, a neuropsychiatrist and professor of psychiatry at the University of Toronto. Feinstein, who delivered the June Halper Memorial Lecture…
The Consortium of Multiple Sclerosis Centers (CMSC) 2026 annual meeting kicks off today in Charlotte, North Carolina, bringing together clinicians, researchers, rehabilitation specialists, and patient advocates for three days of discussions on the latest advances in multiple sclerosis (MS) care and research. At this year’s meeting, CMSC is…
Leaders in multiple sclerosis (MS) research and care are preparing to gather in Charlotte, North Carolina, for the Consortium of MS Centers (CMSC) annual meeting, with this year marking the organization’s 40th anniversary. Multiple Sclerosis News Today sat down with the consortium’s CEO, Kathleen Costello, to discuss the…
Recommended Posts
- My husband has MS, but as a caregiver, this story is mine, too
- Learning new skills could promote myelin repair in MS patients
- Supplement lowers marker of nerve damage in small MS trial
- Don’t neglect hearing issues, even if they’re unrelated to MS
- Researchers to study whether keto diet eases MS vision issues